Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain lactobacillus casei shirota

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Mann, Elizabeth R ^a   You, Jialu ^b   Horneffer Van Der Sluis, Verena ^c   Bernardo, David ^a   Omar Al Hassi, Hafid ^a   Landy, Jon ^a,d   Peake, Simon T ^a,d   Thomas, Linda V ^e   Tee, Cheng T ^a,d   Lee, Gui Han ^a,d   Hart, Ailsa L ^a,d   Yaqoob, Parveen ^b   Knight, Stella C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

^e Yakult UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ARTICLE; CELL FUNCTION; CONDITIONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ACTIVITY; HUMAN; HUMAN TISSUE; LACTOBACILLUS CASEI; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ULCERATIVE COLITIS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; FLOW CYTOMETRY; HOMEOSTASIS; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY;

CELL PROLIFERATION; CELLS, CULTURED; COLITIS, ULCERATIVE; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; HOMEOSTASIS; HUMANS; INFLAMMATION; LACTOBACILLUS CASEI; LYMPHOCYTE ACTIVATION; PROBIOTICS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84881447065     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/573576     Document Type: Article

References (58)

1. Falk P., Exploring the molecular basis of host-microbial interactions in the GI tract. Bioscience and Microflora 2002 21 83 97
2. WHO, Joint FAO/WHO Working Group Report on Drafting Guidelines For the Evaluation of Probiotics in Food 2002
3. Sartor R. B., Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004 126 6 1620 1633 2-s2.0-2442453484 10.1053/j.gastro.2004. 03.024 (Pubitemid 38649878)
4. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli M., Campieri M., Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 2 305 309 2-s2.0-0033860601 (Pubitemid 30621980)
5. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K. M., Brigidi P., Vitali B., Poggioli G., Miglioli M., Campieri M., Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003 124 5 1202 1209 2-s2.0-0038185270 10.1016/S0016-5085(03) 00171-9 (Pubitemid 36531796)
6. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I. C., Nicholls R. J., Gionchetti P., Campieri M., Kamm M. A., Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 1 108 114 2-s2.0-9144254035 10.1136/gut.53.1.108 (Pubitemid 38083018)
7. Kruis W., Frič P., Pokrotnieks J., Lukáš M., Fixa B., Kaščák M., Kamm M. A., Weismueller J., Beglinger C., Stolte M., Wolff C., Schulze J., Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004 53 11 1617 1623 2-s2.0-4644239296 10.1136/gut.2003.037747 (Pubitemid 39434105)
8. Bamias G., Cominelli F., Immunopathogenesis of inflammatory bowel disease: current concepts. Current Opinion in Gastroenterology 2007 23 4 365 369 2-s2.0-34249939158 10.1097/MOG.0b013e3281c55eb2 (Pubitemid 46878946)
9. Baumgart D. C., Carding S. R., Inflammatory bowel disease: cause and immunobiology. The Lancet 2007 369 9573 1627 1640 2-s2.0-34248136828 10.1016/S0140-6736(07)60750-8 (Pubitemid 46722636)
10. Sartor R. B., Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nature Clinical Practice Gastroenterology and Hepatology 2006 3 7 390 407 2-s2.0-33745775434 10.1038/ncpgasthep0528 (Pubitemid 44018812)
11. Strober W., Fuss I., Mannon P., The fundamental basis of inflammatory bowel disease. Journal of Clinical Investigation 2007 117 3 514 521 2-s2.0-33847381116 10.1172/JCI30587 (Pubitemid 46348505)
12. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity. Nature 1998 392 6673 245 252 2-s2.0-0032546352 10.1038/32588 (Pubitemid 28155090)
13. Bell D., Young J. W., Banchereau J., Dendritic cells. Advances in Immunology 1999 72 255 324 2-s2.0-0033493939 (Pubitemid 30224829)
14. Hart D. N. J., Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997 90 9 3245 3287 2-s2.0-0030781916 (Pubitemid 27473395)
15. Hart A. L., Al-Hassi H. O., Rigby R. J., Bell S. J., Emmanuel A. V., Knight S. C., Kamm M. A., Stagg A. J., Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005 129 1 50 65 2-s2.0-22344448660 10.1053/j.gastro.2005.05.013 (Pubitemid 41002042)
16. Verstege M. I., Ten Kate F. J. W., Reinartz S. M., Van Drunen C. M., Slors F. J. M., Bemelman W. A., Vyth-Dreese F. A., Te Velde A. A., Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease. Journal of Histochemistry and Cytochemistry 2008 56 3 233 241 2-s2.0-39449128791 10.1369/jhc.7A7308.2007 (Pubitemid 351272995)
17. Requena L., Requena C., Erythema nodosum. Dermatology Online Journal 2002 8 1 4 2-s2.0-0036598735
18. Adams D. H., Eksteen B., Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nature Reviews Immunology 2006 6 3 244 251 2-s2.0-33344478734 10.1038/nri1784 (Pubitemid 43290993)
19. Hart A. L., Kamm M. A., Knight S. C., Stagg A. J., Prospective evaluation of intestinal homing memory T cells in ulcerative colitis. Inflammatory Bowel Diseases 2004 10 5 496 503 2-s2.0-4644292647 10.1097/00054725-200409000-00002 (Pubitemid 39276455)
20. Hart A. L., Kamm M. A., Knight S. C., Stagg A. J., Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clinical and Experimental Immunology 2004 135 1 137 145 2-s2.0-0347949513 10.1111/j.1365-2249.2004.02347.x (Pubitemid 38067938)
21. Arihiro S., Ohtani H., Suzuki M., Murata M., Ejima C., Oki M., Kinouchi Y., Fukushima K., Sasaki I., Nakamura S., Matsumoto T., Torii A., Toda G., Nagura H., Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease. Pathology International 2002 52 5-6 367 374 2-s2.0-0036019560 10.1046/j.1440-1827.2002.01365.x (Pubitemid 34748219)
22. Briskin M., Winsor-Hines D., Shyjan A., Cochran N., Bloom S., Wilson J., McEvoy L. M., Butcher E. C., Kassam N., Mackay C. R., Newman W., Ringler D. J., Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. The American Journal of Pathology 1997 151 1 97 110 2-s2.0-0030802049 (Pubitemid 27283962)
23. Stagg A. J., Kamm M. A., Knight S. C., Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. European Journal of Immunology 2002 32 1445 1454 (Pubitemid 34546273)
24. Mora J. R., Bono M. R., Manjunath N., Weninger W., Cavanagh L. L., Rosemblatt M., Von Andrian U. H., Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003 424 6944 88 93 2-s2.0-0038264036 10.1038/nature01726 (Pubitemid 36834847)
25. Johansson-Lindbom B., Svensson M., Wurbel M.-A., Malissen B., Márquez G., Agace W., Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. Journal of Experimental Medicine 2003 198 6 963 969 2-s2.0-0141449950 10.1084/jem.20031244 (Pubitemid 37152933)
26. Campbell D. J., Butcher E. C., Rapid acquisition of tissue-specific homing phenotypes by CD4+ T cells activated in cutaneous or mucosal lymphoid tissues. Journal of Experimental Medicine 2002 195 1 135 141 2-s2.0-0037033376 10.1084/jem.20011502 (Pubitemid 34074503)
27. Lefrancois L., Parker C. M., Olson S., Muller W., Wagner N., Schon M. P., Puddington L., The role of β 7 integrins in CD8 T cell trafficking during an antiviral immune response. Journal of Experimental Medicine 1999 189 10 1631 1638 2-s2.0-0033230942 (Pubitemid 29240888)
28. Berlin C., Berg E. L., Briskin M. J., Andrew D. P., Kilshaw P. J., Holzmann B., Weissman I. L., Hamann A., Butcher E. C., α 4 β 7 Integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993 74 1 185 195 2-s2.0-0027237424 10.1016/0092-8674(93)90305-A (Pubitemid 23219889)
29. Berg E. L., McEvoy L. M., Berlin C., Bargatze R. F., Butcher E. C., L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993 366 6456 695 698 2-s2.0-0027756971 10.1038/366695a0 (Pubitemid 24036018)
30. Fuhlbrigge R. C., David Kieffer J., Armerding D., Kupper T. S., Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997 389 6654 978 981 2-s2.0-1842413033 10.1038/40166 (Pubitemid 27485690)
31. Campbell J. J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., Andrew D. P., Warnke R., Ruffing N., Kassam N., Wu L., Butcher E. C., The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999 400 6746 776 780 2-s2.0-0033584358 10.1038/23495 (Pubitemid 29399540)
32. Mitsuyama K., Matsumoto S., Yamasaki H., Masuda J., Kuwaki K., Takedatsu H., Beneficial effects of Lactobacillus casei in ulcerative colitis: a pilot study.
33. Slawik S., Staufenbiel I., Schilke R., Nicksch S., Weinspach K., Stiesch M., Eberhard J., Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans. European Journal of Clinical Nutrition 2011 65 7 857 863 2-s2.0-79960083204 10.1038/ejcn.2011.45
34. Ivory K., Chambers S. J., Pin C., Prieto E., Arqués J. L., Nicoletti C., Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clinical and Experimental Allergy 2008 38 8 1282 1289 2-s2.0-47649087754 10.1111/j.1365-2222. 2008.03025.x (Pubitemid 352019670)
35. Knight S. C., Farrant J., Bryant A., Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology 1986 57 4 595 603 2-s2.0-0022615116 (Pubitemid 16111231)
36. Holden N. J., Bedford P. A., McCarthy N. E., Marks N. A., Ind P. W., Jowsey I. R., Basketter D. A., Knight S. C., Dendritic cells from control but not atopic donors respond to contact and respiratory sensitizer treatment in vitro with differential cytokine production and altered stimulatory capacity. Clinical and Experimental Allergy 2008 38 7 1148 1159 2-s2.0-54449097136 10.1111/j.1365-2222.2008.02997.x
37. Mann E. R., Bernardo D., Al-Hassi H. O., English N. R., Clark S. K., Mccarthy N. E., Milestone A. N., Cochrane S. A., Hart A. L., Stagg A. J., Knight S. C., Human gut-specific homeostatic dendritic cells are generated from blood precursors by the gut microenvironment. Inflammatory Bowel Diseases 2012 18 1275 1286 2-s2.0-80053604587 10.1002/ibd.21893
38. Shida K., Nanno M., Nagata S., Flexible cytokine production by macrophages and t cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2011 2 2 109 114 2-s2.0-79959474557
39. Chirdo F. G., Millington O. R., Beacock-Sharp H., Mowat A. M., Immunomodulatory dendritic cells in intestinal lamina propria. European Journal of Immunology 2005 35 6 1831 1840 2-s2.0-20844443715 10.1002/eji.200425882 (Pubitemid 40862331)
40. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G. M., Nespoli A., Viale G., Allavena P., Rescigno M., Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunology 2005 6 5 507 514 2-s2.0-18244387204 10.1038/ni1192 (Pubitemid 41716764)
41. Butler M., Ng C.-Y., van Heel D. A., Lombardi G., Lechler R., Playford R. J., Ghosh S., Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. European Journal of Immunology 2006 36 4 864 874 2-s2.0-33645954603 10.1002/eji.200535497
42. Iliev I. D., Mileti E., Matteoli G., Chieppa M., Rescigno M., Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunology 2009 2 4 340 350 2-s2.0-67649243735 10.1038/mi.2009.13
43. Lammers K. M., Brigidi P., Vitali B., Gionchetti P., Rizzello F., Caramelli E., Matteuzzi D., Campieri M., Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunology and Medical Microbiology 2003 38 2 165 172 2-s2.0-0142122636 10.1016/S0928-8244(03)00144-5 (Pubitemid 37297842)
44. Lammers K. M., Hart A. L., Brigidi P., Probiotic bacterial DNA induces interleukin-10 production by human dendritic cells via Toll-like receptor-9. International Journal of Probiotics and Prebiotics 2012 7 39 48
45. Bernardo D., Sanchez B., Al-Hassi H. O., Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PLoS One 2012 7 e36262
46. Souza H. S., Elia C. C. S., Spencer J., MacDonald T. T., Expression of lymphocyte-endothelial receptor-ligand pairs, α 4 β 7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999 45 6 856 863 2-s2.0-0032733508
47. Ghosh S., Goldin E., Gordon F. H., Malchow H. A., Rask-Madsen J., Rutgeerts P., Vyhnálek P., Zádorová Z., Palmer T., Donoghue S., Natalizumab for active Crohn's disease. The New England Journal of Medicine 2003 348 1 24 32 2-s2.0-0037413468 10.1056/NEJMoa020732 (Pubitemid 36026343)
48. Sandborn W. J., Colombel J. F., Enns R., Feagan B. G., Hanauer S. B., Lawrance I. C., Panaccione R., Sanders M., Schreiber S., Targan S., Van Deventer S., Goldblum R., Despain D., Hogge G. S., Rutgeerts P., Natalizumab induction and maintenance therapy for Crohn's disease. The New England Journal of Medicine 2005 353 18 1912 1925 2-s2.0-27644441529 10.1056/NEJMoa043335 (Pubitemid 41565956)
49. Targan S. R., Feagan B. G., Fedorak R. N., Lashner B. A., Panaccione R., Present D. H., Spehlmann M. E., Rutgeerts P. J., Tulassay Z., Volfova M., Wolf D. C., Hernandez C., Bornstein J., Sandborn W. J., Natalizumab for the treatment of active crohn's disease: results of the ENCORE trial. Gastroenterology 2007 132 5 1672 1683 2-s2.0-34247884424 10.1053/j.gastro.2007.03.024 (Pubitemid 46695722)
50. Feagan B. G., Greenberg G. R., Wild G., Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. The New England Journal of Medicine 2005 352 2499 2507 (Pubitemid 41007865)
51. Eksteen B., Adams D. H., GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs 2010 13 7 472 481 2-s2.0-77954126169
52. Bernardo D., Vallejo-Díez S., Mann E. R., Al-Hassi H. O., Martínez-Abad B., Montalvillo E., Tee C. T., Murugananthan A. U., Núñez H., Peake S. T. C., Hart A. L., Fernández-Salazar L., Garrote J. A., Arranz E., Knight S. C., IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate. European Journal of Immunology 2012 42 5 1337 1353 2-s2.0-84860333121 10.1002/eji.201142327
53. Gleeson M., Bishop N. C., Oliveira M., Tauler P., Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. International Journal of Sport Nutrition and Exercise Metabolism 2011 21 1 55 64 2-s2.0-79952849961
54. Reale M., Boscolo P., Bellante V., Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. British Journal of Nutrition 2012 108 308 314
55. Habil N., Beal J., Foey A. D., Lactobacillus casei strain Shirota selectively modulates macrophage subset cytokine production. International Journal of Probiotics and Prebiotics 2012 7 1 12
56. Chiba Y., Shida K., Nagata S., Wada M., Bian L., Wang C., Shimizu T., Yamashiro Y., Kiyoshima-Shibata J., Nanno M., Nomoto K., Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Immunology 2010 130 3 352 362 2-s2.0-77953529888 10.1111/j.1365-2567.2009.03204.x
57. Kaji R., Kiyoshima-Shibata J., Nagaoka M., Nanno M., Shida K., Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. Journal of Immunology 2010 184 7 3505 3513 2-s2.0-77951647275 10.4049/jimmunol.0901569
58. Oliva S., Di Nardo G., Ferrari F., Mallardo S., Rossi P., Patrizi G., Cucchiara S., Stronati L., Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 2012 35 3 327 334 2-s2.0-84855355717 10.1111/j.1365-2036.2011.04939.x